Cardiolipid2010 The 13 Annual Lipid Day & Interactive Cardiology ...
Cardiolipid2010 The 13 Annual Lipid Day & Interactive Cardiology ...
Cardiolipid2010 The 13 Annual Lipid Day & Interactive Cardiology ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cardio<strong>Lipid</strong> 2010<strong>13</strong> th <strong>Annual</strong> <strong>Lipid</strong> <strong>Day</strong> &<strong>Interactive</strong> <strong>Cardiology</strong> Course5 th <strong>Annual</strong> meeting of the working group for <strong>Lipid</strong>ology, Vascular biology and Research10‐12 November 2010Dear colleagues, it gives me a great pleasure to invite you to participate in Cardio<strong>Lipid</strong> 2010 which will be held atStella De Mary convention centre, Elsokhna Egypt from 10 to 12 November 2010. In accordance with theobjectives of the working group for lopidology, vascular biology and research (WGLVR), the meeting will focus oncardiovascular protection , the role of different therapeutic modalities with emphasize on intensive medicaltreatment in comparisons with other interventional therapies. <strong>Interactive</strong> case discussion will, as usual, be asignificant part of the congress scientific program. On behalf of the working group for <strong>Lipid</strong>ology, Vascularbiology, and Research (WGLVR) let me wish you fruitful and enjoyable conference.Ashraf Reda MD, FESCPresident of "WGLVR"
About the <strong>Lipid</strong> <strong>Day</strong>:<strong>The</strong> annual lipid day has been started in 1998, the first meeting was held in Shebin ElKom, Menofiya attended atthat time by about 80 experts in the fields of cardiology, Diabetes and cardiovascular protection. <strong>The</strong> extensivediscussion during the meeting and the rapid progression of the knowledge in the field of lipidology andatherosclerosis raised the idea of repeating this meeting annually. From 1998 to 2003 the meeting was heldannually in the second Thursday of Ramadan for one day activity. Since 2004 the <strong>Lipid</strong> day was joined by theannual interactive cardiology course discussing interesting cases with audio‐reply system, not only in the field oflipidology, atherosclerosis and cardiovascular protection, but also in clinical and interventional cardiology. Sincethat time the meeting was held in Stella‐Di Mare conventional centre, El Sokhna, Egypt in 3 days activity. During<strong>The</strong> 8th annual <strong>Lipid</strong> <strong>Day</strong> (2005) the idea and proposed design of a multi‐center clinical survey of the risk factorprofile in Egyptian and Arab patients with acute coronary syndrome (<strong>The</strong> Egyptian Risk Factors and <strong>Lipid</strong> project)was discussed. <strong>The</strong> 9th annual <strong>Lipid</strong> day (2006) celebrated the founding of the Egyptian working group for<strong>Lipid</strong>ology, Vascular Biology and Research (WGLVR), as a division of the Egyptian Society of <strong>Cardiology</strong>. <strong>The</strong>name of the meeting has been changed to Cardio<strong>Lipid</strong> congress. Cardio<strong>Lipid</strong> 2006 included, in addition to the9th annual <strong>Lipid</strong> <strong>Day</strong> and interactive <strong>Cardiology</strong> Coarse, the 1st annual meeting of the working group as well asthe DeltaCardio activity of that year. From 2007 to 2009 the congress faculty included foreign guest experts andhas been internationally recognized and accredited by EBAC
Our MissionLowering cholesterol in the community and,Improving standards of patient care through,Providing accurate medical information and,Improving national data base by,Developing and supporting medical research
Wednesday, 10/Nov/2010Hall: Main16:30 17:50CME I: <strong>Lipid</strong>ology Education program (Understanding the fundamentals of lipid metabolism)Chairpersons Abdallah Abou Hashem Ayman El SaeidMagdy El KhademSameh EmilModeratorsMohamed ElnoamanyFayez FayekTarek El Khouly16:30 - 16:45 LDL: <strong>The</strong> atherogenic lipoproteinNasser Taha16:45 - 16:50 DiscussionMenia16:50 - 17:05 HDL metabolismHesham Aboul Einein17:05 - 17:10 DiscussionBanha17:10 - 17:25 Non-HDL cholesterol as a therapeutic targetMohamed Wafaie A. Enein Zagazig17:25 - 17:30 Discussion17:30 - 17:45 Case presentation (Combined dyslipidemia: case management)Mohamed OrabySuez Canal17:45 - 17:50 Discussion
Wednesday, 10/Nov/2010Hall: Main17:50 19:10Plenary I: <strong>Lipid</strong>ology and vascular biologyChairpersons Ahmed Shafiea Ammar Ahmed AbdelaatySalwa RoshdySaid khalidModeratorsSoliman GhareebMokhtar GomaaAbdelhaleem aboelmagd17:50 - 18:05 Managing the residual risk: <strong>The</strong> role of combinationtherapySameh ShaheenAin Shams18:05 - 18:10 Discussion18:10 - 18:25 the role of omega III FA in CV risk reductionOmar AwwadAin Shams18:25 - 18:30 Discussion18:30 - 18:45 Current Targets and Treatment Gaps in <strong>Lipid</strong><strong>The</strong>rapy: A focus on HDL-CTarek El ZawawyAlexandria18:45 - 18:50 Discussion18:50 - 19:05 Challenges in CVD Prevention: A focus on theCardiometabolic Risk ContinuumMahmoud HassaneinAlexandria19:05 - 19:10 Discussion
Wednesday, 10/Nov/2010Hall: Main19:10 19:55Sanofi Aventis LectureCoffee Break 19:55 ‐ 20:10
Wednesday, 10/Nov/2010Hall: Main20:10 21:30Plenary II: Up dates in atherosclerosis and risk assessmentChairpersons Hany Abdel Razek May SalamaNabil GobranTarek Abdel MoneimModeratorsWafaa El AroussySherif Mokhtar- Ikram sadekHesham Hasan20:10 - 20:25 CIM thickness and cv riskAhmed Elhawary20:25 - 20:30 DiscussionSuez Canal20:30 - 20:45 Novel proinflammatory pathways within<strong>The</strong> atherosclerotic plaquesAbdel Moneim IbrahimCairo20:45 - 20:50 Discussion20:50 - 21:05 Should every patient with hypertension receive statin?Mohamed GamalAssiut21:05 - 21:10 Discussion21:10 - 21:25 Coronary calcification and CV riskNabil Farag21:25 - 21:30 DiscussionAin Shams
Wednesday, 10/Nov/2010Hall: Main21:30 22:50Plenary III: <strong>Lipid</strong> lowering therapiesChairpersons Ahmed Rozza Ahmed ZaghloulAyman SalehMontaser Al CekellyModeratorsRagab MahfouzKhairy Abdel <strong>Day</strong>emMagdy Rashwan21:30 - 21:45 Vascular benefits of NIACINIhab AttiaAin Shams21:45 - 21:50 Discussion21:50 - 22:05 <strong>Lipid</strong> lowering and revascularizationAhmed MagdyNHI22:05 - 22:10 Discussion22:10 - 22:25 Mipomersen, a new agent that reduces Lp (a) as wellas LDLAtef El BaharyPort Said22:25 - 22:30 Discussion
Wednesday, 10/Nov/2010Hall: Main22:50 23:50Opening CeremonyProf. Aly RamzyProf. Mohamed SobhyProf. Ashraf RedaProf. Mohamed Wafaie A. EneinHonorary Chairman of the EGSCPresident of EGSCPresident of WGLVRConference chairman
Thursday, 11/Nov/2010Hall: Main10:30 11:30Clinical trials sessionChairpersons Ahmed Mowafy El Sayed FaragHala MahfouzMohamed El GawadyModeratorsHelmy ElghawabySamir Abdel KaderTarek Nagib10:30 - 10:40 RECORDOssama Sanad10:40 - 10:45 DiscussionBanha10:45 - 10:55 BARI 2DSamir Wafa10:55 - 11:00 DiscussionAin Shams11:00 - 11:10 CEPHEUSAshraf Reda11:10 - 11:15 DiscussionMenophiya11:15 - 11:25 ACCORDHossam Kandil11:25 - 11:30 DiscussionCairo
Thursday, 11/Nov/2010Hall: Main11:30 12:30Plenary IV: <strong>Lipid</strong> lowering and complicationsChairpersons Abdel Rahman Sharaf Kawkab KhedrPlenary IV: <strong>Lipid</strong> lowering and complicationsKhaled ShoukryMohamed El BazModeratorsReda El EssawyWagdy GalalM Awad Taher11:30 - 11:45 Statin and liver diseaseMedhat El Ashmawy11:45 - 11:50 DiscussionTanta11:50 - 12:05 Statins and DiabetesNabil El Kafrawy12:05 - 12:10 DiscussionMenoufiya12:10 - 12:25 Combination therapy and complicationsJ Eliaslebanon12:25 - 12:30 Discussion
Thursday, 11/Nov/2010Hall:Main12:30 <strong>13</strong>:15RegistryRegistry
Hall: Main<strong>13</strong>:15 14:15Pfizer LectureThursday, 11/Nov/2010Pfizer Lecture
Hall: Main14:15 15:15Plenary V: Vascular Biology: Plaque assessmentThursday, 11/Nov/2010Chairpersons Aly El Abd Amr ZakiAyman Abul MagdAhmed KhashabaModeratorsEzz El SawyGalal El SaiedMohamed Seteiha14:15 - 14:30 IVUS CaseMohamed Sobhy14:30 - 14:35 DiscussionAlexandria14:35 - 14:50 MSCT CaseAdel El Etriby14:50 - 14:55 DiscussionAin Shams14:55 - 15:10 FFR CaseHany Ragy15:10 - 15:15 DiscussionNHILunch/free time 15:15 ‐ 17:00Tea time 17:00 ‐ 17:20
Thursday, 11/Nov/2010Hall: Main17:20 18:20Plenary VI: <strong>Lipid</strong>ologyChairpersons Fathu Makaldy Gamal AbouelnasrAly SaadSherif HafezModeratorsNashwa El HagrassyEmil Sadek- Fahmy EmaraIbtihag Hamdy17:20 - 17:35 ABO- B & A-I: <strong>The</strong> predictive valueYehia KeshkAssiut17:35 - 17:40 Discussion17:40 - 17:55 <strong>The</strong> Future of lipid lowering therapyRamzy El MawardyAin Shams17:55 - 18:00 Discussion18:00 - 18:15 <strong>The</strong>rapeutic LS intervention and CV riskSamir RaflaAlex18:15 - 18:20 Discussion
Thursday, 11/Nov/2010Hall: Main18:20 19:05Servier Lecture
Thursday, 11/Nov/2010Hall:Main19:05 19:55Plenary VIIChairpersons Abdel Fattah Ferer Diaa El MinshawyPlenary VIIHelmy BakrHossam El ShaerModeratorsMoustafa NawarWagdy AyadSaeid Shalaby19:05 - 19:25 Cardiovascular disease in the Middle eastMohsen IbrahimCairo19:25 - 19:30 Discussion19:30 - 19:50 Metabolic Syndrome 2010Khairy Abdel <strong>Day</strong>em19:50 - 19:55 DiscussionAin Shams
Thursday, 11/Nov/2010Hall:Main20:00 21:00MSD LectureMSD Lecture
Thursday, 11/Nov/2010Hall: Main21:05 22:05CME II: Cardiovascular Aspects of CKDChairpersons Ahmed nasar Mohamed Wafaie A. EneinRamzy El MawardySanaa GazarenModeratorsSherif El Tobgi21:05 - 21:20 Pathophysiology and management of DiabeticNephropathyGamal SaadyCairo21:20 - 21:25 Discussion21:25 - 21:40 <strong>Lipid</strong> Lowering <strong>The</strong>rapy in CKDAhmed Taha21:40 - 21:45 DiscussionZagazig21:45 - 22:00 Cardiovascular drug <strong>The</strong>rapy in CKDKarim MahmoudCairo22:00 - 22:05 Discussion
Friday, 12/Nov/2010Hall: Main10:00 11:30Young Investigators ForumModerators Sherif El Tobgi Mohamed Sobhy Ashraf RedaClinical Trails Cardiovascular ResearchEducational WorkshopOpen Discussion Egyptian Young Investigators projectClinical Trails Cardiovascular ResearchOpen Discussion
Change language